AMILORIDE



AMILORIDE

N H N 2 H N H O N Cl N 2 H N N 2 H

SMILES N=C(N)NC(=O)c1nc(Cl)c(N)nc1N
InChIKey XSDQTOBWRPYKKA-UHFFFAOYSA-N

Chemical Properties

Hydrogen bond acceptors 6
Hydrogen bond donors 5
Rotatable bonds 1
Molecular weight (Da) 229.0

Database connections

Ligand site mutations A2A A3


Bioactivities

AMILORIDE

N H N 2 H N H O N Cl N 2 H N N 2 H

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV

Database connections

Ligand site mutations A2A A3


Compound is not listed as a drug.